Physician profile
Lilly Wilson
NPI 1487780383
$1,169.12
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $517 · 2022: $556 · 2023: $79.00 · 2024: $17.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $96.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $96.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $184.56 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $142.50 | 2021-2024 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.70 | 2021-2022 | |
| Novo Nordisk INC | $110.47 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $108.62 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $106.98 | 2021-2022 | |
| Amgen INC. | $75.43 | 2021-2022 | |
| Lilly USA, LLC | $46.40 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.09 | 2021-2022 | |
| Abbott Laboratories | $40.60 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.85 | 2021 | |
| Amarin Pharma, INC. | $36.39 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $30.62 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $29.48 | 2021 | |
| Almatica Pharma LLC | $16.96 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.90 | 2021 | |
| Daiichi Sankyo INC. | $13.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lilly Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.